Solid Biosciences LLC (SLDB)

Solid Biosciences LLC (SLDB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $737M; returns 1 day -4.4%, 1 week +7.1%, 1 year +7.2%.

Solid Biosciences is a clinical-stage life sciences company developing precision genetic medicines for rare neuromuscular and cardiac diseases. The company is currently pre-revenue, with its primary business model centered on the research and development of its pipeline of gene therapy candidates.

Groups SLDB belongs to

• Clinical Stage Biotech
• Gene Therapy
• Duchenne Muscular Dystrophy
• Biotechnology
• Rare Diseases
• Precision Medicine
• Healthcare
• Life Sciences
• R&D

SLDB financial model: income statement, cash flow and balance sheet